Second Korean guidelines for the management of ulcerative colitis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Chang Hwan | - |
dc.contributor.author | Moon, Won | - |
dc.contributor.author | Kim, You Sun | - |
dc.contributor.author | Kim, Eun Soo | - |
dc.contributor.author | Lee, Bo-In | - |
dc.contributor.author | Jung, Yunho | - |
dc.contributor.author | Yoon, Yong Sik | - |
dc.contributor.author | Lee, Heeyoung | - |
dc.contributor.author | Park, Dong Il | - |
dc.contributor.author | Han, Dong Soo | - |
dc.date.accessioned | 2021-07-30T05:20:00Z | - |
dc.date.available | 2021-07-30T05:20:00Z | - |
dc.date.created | 2021-05-11 | - |
dc.date.issued | 2017-01 | - |
dc.identifier.issn | 1598-9100 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/4338 | - |
dc.description.abstract | Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by a relapsing and remitting course. The direct and indirect costs of the treatment of UC are high, and the quality of life of patients is reduced, especially during exacerbation of the disease. The incidence and prevalence of UC in Korea are still lower than those of Western countries, but have been rapidly increasing during the past decades. Various medical and surgical therapies, including biologics, are currently used for the management of UC. However, many challenging issues exist, which sometimes lead to differences in practice between clinicians. Therefore, the IBD study group of the Korean Association for the Study of Intestinal Diseases established the first Korean guidelines for the management of UC in 2012. This is an update of the first guidelines. It was generally made by the adaptation of several foreign guidelines as was the first edition, and encompasses treatment of active colitis, maintenance of remission, and indication of surgery for UC. The specific recommendations are presented with the quality of evidence and classification of recommendations. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ASSOC STUDY INTESTINAL DISEASES | - |
dc.title | Second Korean guidelines for the management of ulcerative colitis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Han, Dong Soo | - |
dc.identifier.doi | 10.5217/ir.2017.15.1.7 | - |
dc.identifier.scopusid | 2-s2.0-85012993485 | - |
dc.identifier.wosid | 000405287100003 | - |
dc.identifier.bibliographicCitation | INTESTINAL RESEARCH, v.15, no.1, pp.7 - 37 | - |
dc.relation.isPartOf | INTESTINAL RESEARCH | - |
dc.citation.title | INTESTINAL RESEARCH | - |
dc.citation.volume | 15 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 7 | - |
dc.citation.endPage | 37 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002193699 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | INFLAMMATORY-BOWEL-DISEASE | - |
dc.subject.keywordPlus | EVIDENCE-BASED CONSENSUS | - |
dc.subject.keywordPlus | ORAL 5-AMINOSALICYLIC ACID | - |
dc.subject.keywordPlus | RANDOMIZED CLINICAL-TRIAL | - |
dc.subject.keywordPlus | CYCLOSPORINE-INDUCED REMISSION | - |
dc.subject.keywordPlus | LONDON POSITION STATEMENT | - |
dc.subject.keywordPlus | FACTOR-ALPHA THERAPY | - |
dc.subject.keywordPlus | TERM-FOLLOW-UP | - |
dc.subject.keywordPlus | LONG-TERM | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordAuthor | Colitis | - |
dc.subject.keywordAuthor | ulcerative | - |
dc.subject.keywordAuthor | Inflammatory bowel disease | - |
dc.subject.keywordAuthor | Disease management | - |
dc.subject.keywordAuthor | Guidelines | - |
dc.identifier.url | https://www.irjournal.org/journal/view.php?doi=10.5217/ir.2017.15.1.7 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.